API MANUFACTURING: Apertus manufactures active pharmaceutical ingredients (APIs) for companies that make finished dosage products and/or develop novel dose delivery systems and formulations. Our focus is providing bulk (Schedule II–V) controlled actives, however non-controlled APIs are also within our project portfolio. ANALYTICAL SERVICES: Apertus performs analytical methods development and services on a variety of instrument platforms. Our primary focus is LC (UV), LCMS and GCMS. We can use existing methods or develop novel methods on a per-project basis. In addition, we can provide methods validation, impurity identification and tech transfer packages. PHARMACEUTICAL SERVICES: Apertus provides services for drug discovery and preclinical development on a kilo-lab scale. We can supply intermediates, specialty chemical synthesis, process optimization and scale-up services. In addition we can aid in characterizing RLDs via dissolution profiles, chemical analysis and microscopy. All services can be provided under cGMP.
Looking for a particular Apertus Pharmaceuticals employee's phone or email?
The Apertus Pharmaceuticals annual revenue was $1 million in 2026.
Nichole Diloretta is the Chief Quality Officer of Apertus Pharmaceuticals.
10 people are employed at Apertus Pharmaceuticals.
Apertus Pharmaceuticals is based in St. Louis, Missouri.
The NAICS codes for Apertus Pharmaceuticals are [32, 32541, 325, 3254].
The SIC codes for Apertus Pharmaceuticals are [283, 28].